Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Kalbfleisch

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cardiology Clinics|February 1, 1985
The management of patients with acute myocardial infarction after successful reperfusion with streptokinaseM J Friedman, J M Kalbfleisch, L Robins, et al.
The American Journal of Cardiology|February 15, 1993
Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study GroupJ M Kalbfleisch, P B Kurnik, U Thadani, et al.
Circulation|September 1, 1996
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II InvestigatorsC Bode, R W Smalling, G Berg, et al.
The American Journal of Cardiology|October 1, 1996
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarctionJ H O'Keefe, C L Grines, M A DeWood, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cardiology Clinics|February 1, 1985
The management of patients with acute myocardial infarction after successful reperfusion with streptokinaseM J Friedman, J M Kalbfleisch, L Robins, et al.
The American Journal of Cardiology|February 15, 1993
Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study GroupJ M Kalbfleisch, P B Kurnik, U Thadani, et al.
Circulation|September 1, 1996
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II InvestigatorsC Bode, R W Smalling, G Berg, et al.
The American Journal of Cardiology|October 1, 1996
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarctionJ H O'Keefe, C L Grines, M A DeWood, et al.
Pageof 1